2B70:F:F-iShares NASDAQ US Biotechnology UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 5.929

Change

+0.02 (+0.25)%

Market Cap

USD 0.49B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

ETFs Containing 2B70:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.05% 51% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.05% 49% F 53% F
Trailing 12 Months  
Capital Gain 10.12% 57% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.12% 56% F 57% F
Trailing 5 Years  
Capital Gain 33.16% 56% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.16% 55% F 48% F
Average Annual (5 Year Horizon)  
Capital Gain 6.84% 76% C+ 73% C
Dividend Return 6.84% 76% C+ 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.90% 37% F 66% D+
Risk Adjusted Return 45.94% 80% B- 82% B
Market Capitalization 0.49B 62% D 50% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.